SynthesisPost reproductive health2023

A systematic review of randomised clinical trials - The safety of vaginal hormones and selective estrogen receptor modulators for the treatment of genitourinary menopausal symptoms in breast cancer survivors.

Ishrat Hussain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.